Business Wire

O-RAN-ALLIANCE

Share
O-RAN ALLIANCE Advances Testing and Integration with Successful O-RAN Global PlugFest Fall 2022

The O-RAN Global PlugFest Fall 2022 was successfully completed in 6 venues across Asia, Europe, and North America, with 106 participating companies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005850/en/

O-RAN ALLIANCE global PlugFests represent a major platform enabling efficient progress of the O-RAN ecosystem through well-organized testing and integration. O-RAN Global PlugFest Fall 2022 is the second O-RAN PlugFest this year. In combination with the Spring PlugFest, the 2022 O-RAN Global PlugFests span across 9 venues with 156 participants, of which many participated at more than one venue.

“Testing and integration at O-RAN PlugFests show increasing maturity of O-RAN technology in all regions,” said Linsheng Liao, O-RAN TIFG Co-chair and Senior Project Manager of CMRI. “Comparing the PlugFest results year to year, we are pleased to see major progress made by the O-RAN ecosystem in conformance and interoperability tests, as well as more advanced end-to-end and network automation scenarios. O-RAN PlugFests greatly contribute to developing commercially available O-RAN networks.”

O-RAN Global PlugFest Fall 2022 in Asia

PlugFest in Japan, hosted by NTT DOCOMO, KDDI, Rakuten Mobile, SoftBank, YRP and YRP R&D Promotion Committee took place at multiple sites in large metropolitan area. Activities focused on:

  • Lab tests and field trials of latency assurance with Near-RT RIC for E2E network slicing
  • Conformance, IOT, E2E testing, including Open Fronthaul and security verification
  • Field tests of mmW backhaul system using O-RAN Fronthaul
  • Multi-vendor vRAN integration
  • Near-RT RIC demo with xApp and E2 nodes
  • Open source demo realizing vRAN application deployment with OpenStack Tacker

In addition to the hosts, participants included AMD AECG, Anritsu, ComWorth, Dell Technologies, DKK, DZS, Fujitsu, HCL, Keysight Technologies, KYOCERA, NEC, NVIDIA, Red Hat, Spirent, TOYO, VIAVI Solutions and Wind River.

PlugFest in South Korea hosted by LG Uplus focused on:

  • 5G O-RAN in-building field trial
  • 5G O-RAN Lab validation
  • Test scenarios including fronthaul conformance test, E2E test, analysis of fronthaul and midhaul interfaces
  • Validation of RIC use case with xApp/rApp and the open interfaces (O1, A1, and E2)

In addition to the hosts, participants included Ciena, DELL Technologies, ETRI, Innowireless, Juniper Networks, Keysight Technologies and Viettel High Technology Industries.

PlugFest in South Korea hosted by SK Telecom focused on:

  • Open Fronthaul interface conformance testing for O-DU and O-RU
  • O-RAN specified interoperability testing between O-DU and O-RU
  • Evaluation of O-RAN based private 5G systems through O-RAN specified E2E tests
  • Performance and functional testing in live indoor environments

In addition to the hosts, participants included ETRI, Hewlett Packard Enterprise, HFR, Intel and Keysight Technologies.

O-RAN Global PlugFest Fall 2022 in Europe

Deutsche Telekom, EANTC, EURECOM, Orange, TIM, Vodafone and BT have teamed up together with Telecom Infra Project (TIP) to host the Joint European O-RAN & TIP PlugFest Fall 2022. The PlugFest was hosted in four European labs, namely EURECOM in Sophia Antipolis, i14y Lab in Berlin, Orange Lab in Paris and TIM Innovation Lab in Torino.

The joint PlugFest has demonstrated complementarities and synergies between O-RAN and TIP as well as between the labs.

Test scenarios focused on:

  • Conformance testing of Open Fronthaul interface of O-RU and O-DU
  • End-to-end multi-vendor integration with functional and performance testing
  • xApps/rApps integration with Near/Non-RT RICs and xApps/rApps functional verification
  • O-Cloud platform performance testing

In addition to the hosts, participants included Aarna Networks, Accelleran, ADVA Optical Networking, Analog Devices, Anritsu, Aspire Technology, Azcom Technology, Calnex Solutions, Capgemini Engineering, Dell Technologies, DZS, Fujitsu, Hewlett Packard Enterprise, highstreet technologies, JMA Wireless, Juniper Networks, Keysight Technologies, Mavenir, Microamp Solutions, MTI, NEC, Net AI, Nokia, Open Networking Foundation, Radisys, Red Hat, Rimedo Labs, Rohde & Schwarz, SIAE MICROELETTRONICA, SOLiD, Spirent, VIAVI Solutions, VMware and VoerEir.

O-RAN Global PlugFest Fall 2022 in North America

PlugFest in North America hosted by CableLabs at the Kyrio OTIC Lab focused on:

  • Multi-vendor O-RAN end-to-end system under test, based on the O-RAN E2E test specification, demonstrating cell capacity for signaling and user-plane traffic load. Moreover, the Fronthaul delay impact on user peak throughput was measured using Fronthaul impairment emulators.
  • Demonstration of O-CU interoperability, based on the O-RAN IOT test specifications, verified traffic scenarios across emulated F1 and Xn interfaces, as well as the open F1 and Xn protocol implementation. In addition, the O-CU demonstrated successful interoperability for F1AP and XnAP global, elementary, and mobility procedures.
  • Near-RT RIC testing for conformance to the O-RAN E2 interface specification (E2AP, E2 SM, E2 SM RC, and E2 SM KPM procedures) were verified following the E2 test specification. Moreover, a QoS xApp was integrated and tested.

In addition to the hosts, participants included Calnex Solutions, Capgemini Engineering, Lumentum Holdings, Radisys Networks, Sunwave Communications, VIAVI Solutions and Xena Networks.

PocFest in North America hosted by UNH-IOL, hosted by AT&T and DISH, took place in four labs:

  • University of New Hampshire InterOperability Lab
  • TIP Community Lab at Meta, Menlo Park CA
  • POWDER Lab and NSF PAWR SITE with the University of Utah
  • COSMOS Lab and NSF PAWR SITE with the Rutgers University, Columbia University, NYU Wireless

Activities focused on testing of conformance and performance of O-RU devices, measurements of energy saving and efficiency, integration of AI/ML for resource pooling and slicing, testing of RIC, xApps, SMO, and end-to-end interoperability testing.

In addition to the hosts, participants included AMD, Anritsu, Calnex, DZS, Fujitsu, HCL, Intel, Keysight Technologies, NEC, Radisys, Rohde & Schwarz, VIAVI Solutions, VVDN, VMware, Vodafone, Wind River and Xena.

About O-RAN ALLIANCE

The O-RAN ALLIANCE is a world-wide community of more than 330 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information, please visit www.o-ran.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005850/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye